The current and future role of biomarkers in type 2 cytokine-mediated asthma management
Assessment and management of asthma is complicated by the heterogeneous pathophysiological mechanisms that underlie its clinical presentation, which are not necessarily reflected in standardized management paradigms and which necessitate an individualized approach to treatment. This is particularly...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
Wiley
2017
|